D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global cancer statistics, CA Cancer J Clin, vol.55, issue.2, pp.74-108, 2002.

S. S. Baxi, D. J. Sher, and D. G. Pfister, Value considerations in the treatment of head and neck cancer: radiation, chemotherapy, and supportive care, Am Soc Clin Oncol Educ Book, pp.296-303, 2014.

S. Singer, J. Langendijk, and N. Yarom, Assessing and improving quality of life in patients with head and neck cancer, Am Soc Clin Oncol Educ Book, 2013.

S. Ghosh-laskar, P. H. Yathiraj, D. Dutta, V. Rangarajan, N. Purandare et al., Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results, Head Neck, vol.38, issue.1, pp.1481-1487, 2016.

B. Fertil and E. P. Malaise, Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy, Int J Radiat Oncol Biol Phys, vol.7, issue.5, pp.621-630, 1981.

N. Chavaudra, J. Bourhis, and N. Foray, Quantified relationship between cellular radiosensitivity, DNA repair defects and chromatin relaxation: a study of 19 human tumour cell lines from different origin, Radiother Oncol, vol.73, issue.3, pp.373-82, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00388960

H. D. Skinner, U. Giri, L. Yang, S. H. Woo, M. D. Story et al., Proteomic profiling identifies PTK2/ FAK as a driver of radioresistance in HPV negative head and neck cancer, Clin Cancer Res, vol.22, issue.18, pp.4643-50, 2016.

J. S. Hall, R. Iype, J. Senra, J. Taylor, L. Armenoult et al., Investigation of radiosensitivity gene signatures in cancer cell lines, PLoS One, vol.9, issue.1, p.86329, 2014.

F. Jerhammar, R. Ceder, S. Garvin, R. Grenman, R. C. Grafstrom et al., Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma, Cancer Biol Ther, vol.10, issue.12, pp.1244-51, 2010.

J. Pramana, M. W. Van-den-brekel, M. L. Van-velthuysen, L. F. Wessels, D. S. Nuyten et al., Gene expression profiling to predict outcome after chemoradiation in head and neck cancer, Int J Radiat Oncol Biol Phys, vol.69, issue.5, pp.1544-52, 2007.

D. De-ridder, C. E. Van-der-linden, T. Schonewille, W. A. Dik, M. J. Reinders et al., Purity for clarity: the need for purification of tumor cells in DNA microarray studies, Leukemia, vol.19, issue.4, pp.618-645, 2005.

K. Yoshihara, M. Shahmoradgoli, E. Martinez, R. Vegesna, H. Kim et al., Inferring tumour purity and stromal and immune cell admixture from expression data, Nat Commun, vol.4, p.2612, 2013.

D. Aran, M. Sirota, and A. J. Butte, Systematic pan-cancer analysis of tumour purity, Nat Commun, vol.6, p.8971, 2015.

K. Lindel, K. T. Beer, J. Laissue, R. H. Greiner, and D. M. Aebersold, Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma, Cancer, vol.92, issue.4, pp.805-818, 2001.

H. Mirghani, F. Amen, Y. Tao, E. Deutsch, and A. Levy, Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives, Cancer Treat Rev, vol.41, issue.10, pp.844-52, 2015.

C. Fakhry, W. H. Westra, S. Li, A. Cmelak, J. A. Ridge et al., Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial, J Natl Cancer Inst, vol.100, issue.4, pp.261-270, 2008.

L. Masterson, D. Moualed, Z. W. Liu, J. E. Howard, R. C. Dwivedi et al., De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials, Eur J Cancer, vol.50, issue.15, pp.2636-2684, 2014.

H. Mirghani, F. Amen, P. Blanchard, F. Moreau, J. Guigay et al., Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives, Int J Cancer, vol.136, issue.7, pp.1494-503, 2015.

A. C. Jung, S. Guihard, S. Krugell, S. Ledrappier, A. Brochot et al., CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis, Int J Cancer, vol.132, issue.2, pp.26-36, 2013.

T. M. Pawlik and K. Keyomarsi, Role of cell cycle in mediating sensitivity to radiotherapy, Int J Radiat Oncol Biol Phys, vol.59, issue.4, pp.928-970, 2004.

A. Jedlinski, A. Ansell, A. C. Johansson, and K. Roberg, EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines, J Oral Pathol Med, vol.42, issue.1, pp.26-36, 2013.

F. Perri, R. Pacelli, D. V. Scarpati, G. Cella, L. Giuliano et al., Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications, Head Neck, vol.37, issue.5, pp.763-70, 2015.

M. C. De-jong, T. Hoeve, J. J. Grenman, R. Wessels, L. F. Kerkhoven et al., Pretreatment microRNA expression impacting on epithelial-to-mesenchymal transition predicts intrinsic radiosensitivity in head and neck cancer cell lines and patients, Clin Cancer Res, vol.21, issue.24, pp.5630-5638, 2015.

C. H. Chung, J. S. Parker, G. Karaca, J. Wu, W. K. Funkhouser et al., Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression, Cancer Cell, vol.5, issue.5, pp.489-500, 2004.

V. Walter, X. Yin, M. D. Wilkerson, C. R. Cabanski, N. Zhao et al., Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes, PLoS One, vol.8, issue.2, p.56823, 2013.

U. T. Shankavaram, S. Varma, D. Kane, M. Sunshine, K. K. Chary et al., Cell Miner: a relational database and query tool for the NCI-60 cancer cell lines, BMC Genomics, vol.10, p.277, 2009.

W. C. Reinhold, M. Sunshine, H. Liu, S. Varma, K. W. Kohn et al., Cell Miner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set, Cancer Res, vol.72, issue.14, pp.3499-511, 2012.

S. A. Amundson, K. T. Do, L. C. Vinikoor, R. A. Lee, C. A. Koch-paiz et al., Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen, Cancer Res, vol.68, issue.2, pp.415-439, 2008.

H. S. Kim, S. C. Kim, S. J. Kim, C. H. Park, H. C. Jeung et al., Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells, BMC Genomics, vol.13, p.348, 2012.

F. Iorio, T. A. Knijnenburg, D. J. Vis, G. R. Bignell, M. P. Menden et al., A landscape of pharmacogenomic interactions in cancer, Cell, vol.166, issue.3, pp.740-54, 2016.

W. Yang, J. Soares, P. Greninger, E. J. Edelman, H. Lightfoot et al., Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells, Nucleic Acids Res, vol.41, pp.955-961, 2013.

Y. W. Wan, G. I. Allen, and Z. Liu, TCGA2STAT: simple TCGA data access for integrated statistical analysis in R, Bioinformatics, vol.32, issue.6, pp.952-956, 2016.

B. Institute and T. Center, Broad Institute TCGA Genome Data Analysis Center: SNP6 Copy number analysis (GISTIC2), Broad Institute of MIT and Harvard, Mutation Analysis (MutSig v2.0), 2016.

C. H. Mermel, S. E. Schumacher, B. Hill, M. L. Meyerson, R. Beroukhim et al., GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers, Genome Biol, vol.12, issue.4, p.41, 2011.

E. Cerami, J. Gao, U. Dogrusoz, B. E. Gross, S. O. Sumer et al., The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, vol.2, issue.5, pp.401-405, 2012.

J. Gao, B. A. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross et al., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, vol.6, issue.269, p.1, 2013.

J. Li, Y. Lu, R. Akbani, Z. Ju, P. L. Roebuck et al., TCPA: a resource for cancer functional proteomics data, Nat Methods, vol.10, issue.11, pp.1046-1053, 2013.

M. A. Kuriakose, W. T. Chen, Z. M. He, A. G. Sikora, P. Zhang et al., Selection and validation of differentially expressed genes in head and neck cancer, Cell Mol Life Sci, vol.61, issue.11, pp.1372-83, 2004.

G. Wichmann, M. Rosolowski, K. Krohn, M. Kreuz, A. Boehm et al., The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer, Int J Cancer, vol.137, issue.12, pp.2846-57, 2015.

D. A. Barbie, P. Tamayo, J. S. Boehm, S. Y. Kim, S. E. Moody et al., Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1, Nature, vol.462, issue.7269, pp.108-120, 2009.

A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci, vol.102, issue.43, pp.15545-50, 2005.

A. Liberzon, C. Birger, H. Thorvaldsdottir, M. Ghandi, J. P. Mesirov et al., The Molecular Signatures Database (MSigDB) hallmark gene set collection, Cell Syst, vol.1, issue.6, pp.417-442, 2015.

S. Dudoit, R. C. Gentleman, and J. Quackenbush, Open source software for the analysis of microarray data, Biotechniques, pp.45-51, 2003.

M. Reich, T. Liefeld, J. Gould, J. Lerner, P. Tamayo et al., GenePattern 2.0, Nat Genet, vol.38, issue.5, pp.500-501, 2006.

M. G. Marcu, M. Doyle, A. Bertolotti, D. Ron, L. Hendershot et al., Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha, Mol Cell Biol, vol.22, issue.24, pp.8506-8519, 2002.

E. J. Born, S. V. Hartman, and S. A. Holstein, Targeting HSP90 and monoclonal protein trafficking modulates the unfolded protein response, chaperone regulation and apoptosis in myeloma cells, Blood Cancer J, vol.3, p.167, 2013.

K. Wong, G. P. Delaney, and M. B. Barton, Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand, Radiother Oncol, vol.119, issue.1, pp.145-154, 2016.

S. A. Eschrich, J. Pramana, H. Zhang, H. Zhao, D. Boulware et al., A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation, Int J Radiat Oncol Biol Phys, vol.75, issue.2, pp.489-96, 2009.

C. Hetz, E. Chevet, and H. P. Harding, Targeting the unfolded protein response in disease, Nat Rev Drug Discov, vol.12, issue.9, pp.703-722, 2013.